Was the Myriad Decision a ‘Surgical Strike’ on Isolated DNA Patents, or Does it Have Wider Impacts?
36(12) Nature Biotechnology 1146
6 Pages Posted: 27 Jun 2019 Last revised: 18 Sep 2019
Date Written: December 6, 2018
Five years later, what are the wider impacts of the US Supreme Court’s Myriad decision on subject-matter eligibility and patent prosecution for nature-based products beyond isolated DNA?
Keywords: patents, gene patents, Myriad, wider impacts, DNA, markedly different, naturally occurring compounds, empirical, Biotechnology, US
Suggested Citation: Suggested Citation